Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0LB2 stock hub

LON/0LB2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LB2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LB2

In the news

Latest news · LON/0LB2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.6

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-2.8

P25 -54.2P50 2.1P75 13.7

ROIC3.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LB2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	778
Employees Change	104%
Employees Change Percent	15.43
Enterprise value	$1.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US8684591089
Last refreshed	2026-05-10
Market cap	$2.2B
Price	$51.81
Price currency	USD
Rev Per Employee	756,169.04x
Sector	Healthcare
Sic	2834
Symbol	lon/0LB2
Website	https://www.supernus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1%
EV Earnings	-88.42x
EV/EBIT	104.58x
EV/EBITDA	19.09x
EV/FCF	31.19x
EV/Sales	3.41x
FCF yield	2.84%
Forward P/E	19.59x
P/B ratio	2.69x
P/S ratio	3.73x
PE Ratio10 Y	64.34x
PE Ratio3 Y	211.42x
PE Ratio5 Y	120.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.26%
EBITDA Margin	15.79%
FCF margin	10.59%
Gross margin	74.13%
Gross Profit	$436.1M
Gross Profit Growth	26.59%
Gross Profit Growth Q	35.23%
Gross Profit Growth3 Y	0.01%
Gross Profit Growth5 Y	3.15%
Net Income	$-22M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-6.33%
Profit Margin	-3.74%
Profit Per Employee	$-28,244
ROA	1.11
Roa5y	1.88
ROCE	2.25
ROE	-2.75
Roe5y	3.6
ROIC	3.32
Roic5y	4.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	69.68%
Cagr3y	12.72%
Cagr5y	11.75%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	-49.65%
FCF Growth Q	119.75%
FCF Growth3 Y	-20.19%
FCF Growth5 Y	-12.74%
OCF Growth	-49.28%
OCF Growth Q	117.41%
OCF Growth10 Y	10.16%
OCF Growth3 Y	-19.84%
OCF Growth5 Y	-12.86%
Revenue Growth	16.29x
Revenue Growth Q	38.63x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	5.13x
Revenue Growth5 Y	6.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$1.1B
Cash	$291M
Current Assets	$536.6M
Current Liabilities	$274.3M
Debt	$31M
Debt EBITDA	$0.29
Debt Equity	$0.04
Debt FCF	$0.5
Equity	$815.5M
Liabilities	$321M
Long Term Assets	$599.9M
Long Term Liabilities	$46.8M
Net Cash	$260M
Net Cash By Market Cap	$11.85
Net Cash Growth	-20.39%
Net Debt EBITDA	$-2.8
Net Debt Equity	$-0.32
Net Debt FCF	$-4.17
Tangible Book Value	$307.8M
Tangible Book Value Per Share	$5.3
WACC	7.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.96
Inventory Turnover	2.94
Net Working Capital	$-12.1M
Quick ratio	1.51
Working Capital	$270.9M
Working Capital Turnover	$1.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	69.62%
200-day SMA	46.87
3Y total return	43.22%
50-day SMA	51.09
50-day SMA vs 200-day SMA	50over200
5Y total return	74.27%
All Time High	60.75
All Time High Change	-14.72%
All Time High Date	2018-06-29
All Time Low	21.87
All Time Low Change	136.9%
All Time Low Date	2020-12-14
ATR	1.62
Beta	0.57
Ch YTD	2.56
High	53.01
High52	59.74
High52 Date	2026-02-25
High52ch	-13.27%
Low	51.81
Low52	31.1
Low52 Date	2025-06-04
Low52ch	72.24%
Ma50ch	1.41%
Price vs 200-day SMA	10.54%
RSI	55.48
RSI Monthly	60.99
RSI Weekly	56.63
Sharpe ratio	1.21x
Sortino ratio	1.96
Total Return	-1.57%
Tr YTD	2.56
Tr1m	3.02%
Tr1w	8.62%
Tr3m	1.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$19.2M
Operating Income Growth	-56.8
Operating Income Growth3 Y	-18.35
Operating Income Growth5 Y	-31.61
Operating margin	3.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,247,461%
Shares Insiders	4.3%
Shares Institutions	96.46%
Shares Qo Q	0.53%
Shares Yo Y	1.57%
Short Ratio	6.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$36.9M
Average Volume	95.3x
Bv Per Share	14.05
CAPEX	$-765,635
Ch1m	3.02
Ch1w	8.62
Ch1y	69.62
Ch3m	1.56
Ch3y	43.22
Ch5y	74.27
Ch6m	11.13
Change	-0.8%
Change From Open	-2.26
Close	52.23
Days Gap	1.49
Depreciation Amortization	71,379,714.4
Earnings Date	2026-05-05
EBIT	$19.2M
EBITDA	$92.9M
EPS	$-0.39
F Score	5
FCF	$62.3M
FCF EV Yield	3.21x
Financing CF	30,022,599
Fiscal Year End	December
Founded	2,005
Goodwill	88,511,667.4
Income Tax	$-15.2M
Investing CF	-39,704,744
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	49.6
Ma150ch	4.45%
Ma20	50.19
Ma20ch	3.23%
Net CF	53,368,041
Open	53.01
P FCF Ratio	35.24
P OCF Ratio	34.81
Position In Range	0
Ppne	26,728,516.6
Price Date	2026-05-08
Price EBITDA	$23.63
Ptbv Ratio	7.13
Relative Volume	2.18x
Revenue	588,299,515x
SBC By Revenue	4.31x
Share Based Comp	25,341,697
Tax By Revenue	-2.59x
Tr6m	11.13%
Z Score	4.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0LB2 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0LB2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LB2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+96.5%

Share of float held by funds and institutions

Insider ownership

+4.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LB2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.5

Neutral momentum band

Price vs 200-day MA

+10.5%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LB2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LB2 stock rating?

lon/0LB2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LB2 analysis?

The full report lives at /stocks/lon/0LB2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LB2?

The latest report frames lon/0LB2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LB2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.